Role of helicity of α-helical antimicrobial peptides to improve specificity

Abstract

A major barrier to the use of antimicrobial peptides as antibiotics is the toxicity or ability to lyse eukaryotic cells. In this study, a 26-residue amphipathic α-helical antimicrobial peptide A12L/A20L (Ac-KWKSFLKTFKSLK KTVLHTLLKAISS-amide) was used as the framework to design a series of D- and L-diastereomeric peptides and study the relationships of helicity and biological activities of α-helical antimicrobial peptides. Peptide helicity was measured by circular dichroism spectroscopy and demonstrated to correlate with the hydrophobicity of peptides and the numbers of D-amino acid substitutions. Therapeutic index was used to evaluate the selectivity of peptides against prokaryotic cells. By introducing D-amino acids to replace the original L-amino acids on the non-polar face or the polar face of the helix, the hemolytic activity of peptide analogs have been significantly reduced. Compared to the parent peptide, the therapeutic indices were improved of 44-fold and 22-fold against Gram-negative and Grampositive bacteria, respectively. In addition, D- and L-diastereomeric peptides exhibited lower interaction with zwitterionic eukaryotic membrane and showed the significant membrane damaging effect to bacterial cells. Helicity was proved to play a crucial role on peptide specificity and biological activities. By simply replacing the hydrophobic or the hydrophilic amino acid residues on the non-polar or the polar face of these amphipathic derivatives of the parent peptide with D-amino acids, we demonstrated that this method could have excellent potential for the rational design of antimicrobial peptides with enhanced specificity.

Key words： antimicrobial peptides (AMPs); peptide antibiotics; helicity; secondary structure; diastereomeric peptides; specificity; therapeutic index

References

1 Brinckerhoff LH, Kalashnikov VV, Thompson LW, Yamshchikov GV, Pierce RA, Galavotti HS, Engelhard VH, Slingluff CL Jr (1999) Terminal modifflcations inhibit proteolytic degradation of an immunogenic MART-1(27-35) peptide: implications for peptide vaccines. Int J Cancer83: 326-334

2 Chen Y, Mant CT, Hodges RS (2002) Determination of stereochemistry stability coefflcients of amino acid side-chains in an amphipathic alpha-helix. J Pept Res59: 18-33

3 Chen Y, Mant CT, Farmer SW, Hancock RE, Vasil ML, Hodges RS(2005) Rational design of alpha-helical antimicrobial peptides with enhanced activities and speciflcity/therapeutic index. J Biol Chem280: 12316-12329

4 Chen Y, Guarnieri MT, Vasil AI, Vasil ML, Mant CT, Hodges RS(2007) Role of peptide hydrophobicity in the mechanism of action of alpha-helical antimicrobial peptides. Antimicrob Agents Chemother51: 1398-1406

5 Chen C, Hu J, Zhang S, Zhou P, Zhao X, Xu H, Yaseen M, Lu JR(2012) Molecular mechanisms of antibacterial and antitumor actions of designed surfactant-like peptides. Biomaterials33: 592-603

6 Eftink MR, Ghiron CA(1976) Exposure of tryptophanyl residues in proteins. Quantitative determination by fluorescence quenching studies. Biochemistry15: 672-680

7 Ehrenstein G, Lecar H(1977) Electrically gated ionic channels in lipid bilayers. Q Rev Biophys10: 1-34

8 Hancock RE, Rozek A(2002) Role of membranes in the activities of antimicrobial cationic peptides. FEMS Microbiol Lett206: 143-149

9 Hong J, Oren Z, Shai Y(1999) Structure and organization of hemolytic and nonhemolytic diastereomers of antimicrobial peptides in membranes. Biochemistry38: 16963-16973

10 Huang JF, Xu YM, Hao DM, Huang YB, Liu Y, Chen YX(2010a) Structure-guided de novo design of alpha-helical antimicrobial peptide with enhanced speciflcity. Pure Appl Chem82: 243-257

11 Huang Y, Huang J, Chen Y(2010b) Alpha-helical cationic antimicrobial peptides: relationships of structure and function. Protein Cell1: 143-152

12 Huang YB, Wang XF, Wang HY, Liu Y, Chen Y(2011) Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a deflned structural framework. Mol Cancer Ther10: 416-426

13 Huang YB, He LY, Jiang HY, Chen YX(2012) Role of helicity on the anticancer mechanism of action of cationic-helical peptides. Int J Mol Sci13: 6849-6862

14 Jenssen H, Hamill P, Hancock RE(2006) Peptide antimicrobial agents. Clin Microbiol Rev19: 491-511

15 Jiang Z, Vasil AI, Hale JD, Hancock RE, Vasil ML, Hodges RS(2008) Effects of net charge and the number of positively charged residues on the biological activity of amphipathic alpha-helical cationic antimicrobial peptides. Biopolymers90: 369-383

16 Lee DL, Mant CT, Hodges RS(2003) A novel method to measure self-association of small amphipathic molecules: temperature proflling in reversed-phase chromatography. J Biol Chem278: 22918-22927

17 Mant CT, Chen Y, Hodges RS(2003) Temperature proflling of polypeptides in reversed-phase liquid chromatography. I. Monitoring of dimerization and unfolding of amphipathic alpha-helical peptides. J Chromatogr A1009: 29-43

18 Matsuzaki K, Murase O, Fujii N, Miyajima K(1995) Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry34: 6521-6526

19 Mayer LD, Hope MJ, Cullis PR, Janoff AS(1985) Solute distributions and trapping efflciencies observed in freeze-thawed multilamellar vesicles. Biochim Biophys Acta817: 193-196

20 Nguyen LT, Chau JK, Perry NA, de Boer L, Zaat SA, Vogel HJ(2010) Serum stabilities of short tryptophan- and arginine-rich antimicrobial peptide analogs. PLoS One5: e12684

21 Oren Z, Shai Y(1997) Selective lysis of bacteria but not mammalian cells by diastereomers of melittin: structure-function study. Biochemistry36: 1826-1835

22 Oyston PC, Fox MA, Richards SJ, Clark GC(2009) Novel peptide therapeutics for treatment of infections. JMedMicrobiol58: 977-987

23 Pag U, Oedenkoven M, Papo N, Oren Z, Shai Y, Sahl HG(2004) In vitro activity and mode of action of diastereomeric antimicrobial peptides against bacterial clinical isolates. J Antimicrob Chemother53: 230-239

24 Papo N, Oren Z, Pag U, Sahl HG, Shai Y(2002) The consequence of sequence alteration of an amphipathic alpha-helical antimicrobial peptide and its diastereomers. J Biol Chem277: 33913-33921

25 Papo N, Shahar M, Eisenbach L, Shai Y(2003) A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J Biol Chem278: 21018-21023

26 Prenner EJ, Kiricsi M, Jelokhani-Niaraki M, Lewis RN, Hodges RS, McElhaney RN(2005) Structure-activity relationships of diastereomeric lysine ring size analogs of the antimicrobial peptide gramicidin S: mechanism of action and discrimination between bacterial and animal cell membranes. J Biol Chem280: 2002-2011

27 Shai Y(1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta1462: 55-70

28 Shai Y, Oren Z(1996) Diastereoisomers of cytolysins, a novel class of potent antibacterial peptides. J Biol Chem271: 7305-7308

29 Shai Y, Oren Z(2001) From “carpet” mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides22: 1629-1641

30 Stark M, Liu LP, Deber CM(2002) Cationic hydrophobic peptides with antimicrobial activity. Antimicrob Agents Chemother46: 3585-3590

31 Wang G, Li X, Wang Z(2009a) APD2: the updated antimicrobial peptide database and its application in peptide design. Nucleic Acids Res37: D933-D937

32 Wang P, Bang JK, Kim HJ, Kim JK, Kim Y, Shin SY(2009b) Antimicrobial speciflcity and mechanism of action of disulflderemoved linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1. Peptides30: 2144-2149

33 Wiradharma N, Khoe U, Hauser CA, Seow SV, Zhang S, Yang YY(2011) Synthetic cationic amphiphilic alpha-helical peptides as antimicrobial agents. Biomaterials32: 2204-2212

34 Zhang L, Benz R, Hancock RE(1999) Influence of proline residues on the antibacterial and synergistic activities of alpha-helical peptides. Biochemistry38: 8102-8111

35 Zhou NE, Mant CT, Hodges RS(1990) Effect of preferred binding domains on peptide retention behavior in reversed-phase chromatography: amphipathic alpha-helices. Pept Res3: 8-20